Cargando…
Crushing lopinavir-ritonavir tablets may decrease the efficacy of therapy in COVID-19 patients
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263273/ https://www.ncbi.nlm.nih.gov/pubmed/32473994 http://dx.doi.org/10.1016/j.tmaid.2020.101749 |
| _version_ | 1783540779644354560 |
|---|---|
| author | Eljaaly, Khalid Al-Tawfiq, Jaffar A. |
| author_facet | Eljaaly, Khalid Al-Tawfiq, Jaffar A. |
| author_sort | Eljaaly, Khalid |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7263273 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72632732020-06-02 Crushing lopinavir-ritonavir tablets may decrease the efficacy of therapy in COVID-19 patients Eljaaly, Khalid Al-Tawfiq, Jaffar A. Travel Med Infect Dis Article Elsevier Ltd. 2020 2020-05-28 /pmc/articles/PMC7263273/ /pubmed/32473994 http://dx.doi.org/10.1016/j.tmaid.2020.101749 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Eljaaly, Khalid Al-Tawfiq, Jaffar A. Crushing lopinavir-ritonavir tablets may decrease the efficacy of therapy in COVID-19 patients |
| title | Crushing lopinavir-ritonavir tablets may decrease the efficacy of therapy in COVID-19 patients |
| title_full | Crushing lopinavir-ritonavir tablets may decrease the efficacy of therapy in COVID-19 patients |
| title_fullStr | Crushing lopinavir-ritonavir tablets may decrease the efficacy of therapy in COVID-19 patients |
| title_full_unstemmed | Crushing lopinavir-ritonavir tablets may decrease the efficacy of therapy in COVID-19 patients |
| title_short | Crushing lopinavir-ritonavir tablets may decrease the efficacy of therapy in COVID-19 patients |
| title_sort | crushing lopinavir-ritonavir tablets may decrease the efficacy of therapy in covid-19 patients |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263273/ https://www.ncbi.nlm.nih.gov/pubmed/32473994 http://dx.doi.org/10.1016/j.tmaid.2020.101749 |
| work_keys_str_mv | AT eljaalykhalid crushinglopinavirritonavirtabletsmaydecreasetheefficacyoftherapyincovid19patients AT altawfiqjaffara crushinglopinavirritonavirtabletsmaydecreasetheefficacyoftherapyincovid19patients |